Monopar Therapeutics
MNPR
#7582
Rank
ยฃ0.36 B
Marketcap
ยฃ54.50
Share price
-0.94%
Change (1 day)
-6.09%
Change (1 year)

EPS for Monopar Therapeutics (MNPR)

EPS in 2026 (TTM): -ยฃ1.43

According to Monopar Therapeutics's latest financial reports the company's current EPS (TTM) is -ยฃ1.45. In 2025 the company made an earnings per share (EPS) of -ยฃ1.40 an increase over its 2024 EPS that were of -ยฃ3.11.

EPS history for Monopar Therapeutics from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ1.431.91%
2025-ยฃ1.40-54.99%
2024-ยฃ3.1135.2%
2023-ยฃ2.30-26.75%
2022-ยฃ3.1413.7%
2021-ยฃ2.7625.86%
2020-ยฃ2.2028.89%
2019-ยฃ1.7045.28%
2018-ยฃ1.17-80.5%
2017-ยฃ6.011296.33%
2016-ยฃ0.43

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-ยฃ1.02-29.32%๐Ÿ‡บ๐Ÿ‡ธ USA